APA (7th ed.) Citation

Roney, M., Uddin, M. N., Khan, A. A., Fatima, S., Mohd Fadhlizil Fasihi, M. A., Hamim, S. I., & Ahmad, A. (2025). Repurposing of dipeptidyl peptidase FDA-approved drugs in Alzheimer's disease using network pharmacology and in-silico approaches. Elsevier Ltd.

Chicago Style (17th ed.) Citation

Roney, Miah, Md. Nazim Uddin, Azmat Ali Khan, Sabiha Fatima, Mohd Aluwi Mohd Fadhlizil Fasihi, S.M. Istiaque Hamim, and Asrar Ahmad. Repurposing of Dipeptidyl Peptidase FDA-approved Drugs in Alzheimer's Disease Using Network Pharmacology and In-silico Approaches. Elsevier Ltd, 2025.

MLA (9th ed.) Citation

Roney, Miah, et al. Repurposing of Dipeptidyl Peptidase FDA-approved Drugs in Alzheimer's Disease Using Network Pharmacology and In-silico Approaches. Elsevier Ltd, 2025.